This inventor holds 1 USPTO granted patent. Top assignee: E. R. Squibb Sons, Inc.. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: Anne M Delargy: Innovator in Pharmaceutical Compositions
Introduction
Anne M Delargy is a notable inventor based in Merseyside, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance drug delivery. Her innovative approach has led to the creation of a unique pharmaceutical composition that addresses critical challenges in the industry.
Latest Patents
Anne M Delargy holds a patent for a pharmaceutical composition containing a high drug load. This composition is prepared in the form of beads using an extrusion-spheronization technique. It contains more than 80% by weight of the drug and less than 15% by weight of a non-lipophilic binder-plasticizer, such as microcrystalline cellulose. This formulation achieves the required plasticity for processing and includes a starch-based excipient to control water distribution and inhibit agglomeration. Additionally, a water-soluble binder is used to ensure the final beads are less friable. The method for preparing these beads also involves the addition of a granulating agent to improve blend properties during spheronization.
Career Highlights
Throughout her career, Anne has demonstrated a commitment to advancing pharmaceutical technology. Her work at E. R. Squibb Sons, Inc. has allowed her to collaborate with other experts in the field, further enhancing her contributions to innovative drug formulations.
Collaborations
One of her notable collaborators is John R Howard, with whom she has worked closely to develop her patented pharmaceutical compositions. Their partnership has been instrumental in refining the methods and applications of their inventions.
Conclusion
Anne M Delargy is a pioneering inventor whose work in pharmaceutical compositions has the potential to significantly impact drug delivery systems. Her innovative approaches and collaborations continue to drive advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
